Eight Treg

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire De Nantes, Nantes University Hospital

Conditions

Kidney Transplantationchronic renal failure requiring kidney transplantation

Phase 1

Eight-Treg study: a phase I dose escalation trial of adoptive immunotherapy with autologous ex vivo expanded regulatory CD8+ T cells in living donor kidney transplant recipients

RecruitingCTIS2024-513771-40-01

Centre Hospitalier Universitaire De Nanteschronic renal failure requiring kidney transplantation

Start: 2025-03-03Target: 9Updated: 2024-12-20

Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients

Not yet recruitingNCT06777719

Nantes University HospitalKidney Transplantation

Start: 2025-02-01End: 2027-04-15Target: 9Updated: 2025-01-16